# CSL breaks ground on $1.5B expansion of Illinois plasma therapy manufacturing facility

CSL broke ground on a $1.5 billion expansion of its plasma-derived therapies manufacturing facility in Kankakee, Illinois, on March 9, 2026. The expansion will create at least 300 new jobs and is expected to be operational by 2031.

- Type: Expansion
- Announced: 2026-03-09
- Where: Kankakee, Illinois, United States
- Value: $1.50B
- Jobs: 300
- Starts operating: 2031
- Status: under construction
- Products: plasma-derived therapies, albumin
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CSL](https://endata.com/companies/3244.md)

## Sources

- [newsroom.csl.com](https://newsroom.csl.com/2026-03-09-CSL-announces-expansion-of-Illinois-plasma-therapy-manufacturing-facility), 2026-03-09: "This site expansion marks an important step in our commitment to serving patients with rare and serious diseases."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.